This monthly compilation highlights recent executive movements within the healthcare industry and is not exhaustive. If you have news of executive appointments, resignations, or layoffs to include, please contact us at [email protected].
Hires and promotions
Adonis, an AI startup addressing hospitals’ denied and underpaid claims, appointed Alison Bloom‑Kiefer as chief product officer and promoted Doug Pickett to chief revenue officer. Ms. Bloom‑Kiefer joins from Oscar Health, where she was vice president of provider experience strategy and innovation. Mr. Pickett joined Adonis in 2023 as director of strategic sales; previously he held the role of vice president of commercial strategy at Cedar.
North Carolina‑based Cone Health named Ryan Christensen as chief value‑based care officer. Mr. Christensen comes from Intermountain Health, where he served as enterprise vice president of operations for proactive care services.
Humana welcomed J.P. Holland as its new Medicaid president. He previously was CEO of Johns Hopkins Health Plans and earlier led Elevance Health’s Alliance Business as its CEO.
Mayo Clinic appointed Arun Kumar Bhaskara‑Baba as its new chief information officer. He previously served as CIO at Honeywell Aerospace and Defense.
Merck added Bart Gourley as the company’s chief artificial intelligence officer. Mr. Gourley has held senior leadership roles at EY, Amazon, and Accenture.
Providence named Kevin Smith as its new chief financial officer. Mr. Smith will assume the role in October, transitioning from his position as CFO of SSM Health.
Care navigation company Quantum Health hired Jamie Hall as its chief commercial officer and Daniel Stein as its chief strategy officer. Mr. Hall joined through Quantum’s acquisition of CirrusMD, and Mr. Stein came via Quantum’s purchase of Embold Health.
Exits
Centene CFO Drew Asher will retire at year‑end after serving in the role since 2021.
Two senior leaders at Tufts Medicine—CEO Mike Dandorph and CFO Andrew Devoe—have announced they will step down as the health system initiates a major financial turnaround.
Layoffs
Cellares, a cell‑therapy manufacturing specialist, plans to lay off roughly 100 employees after Bristol Myers Squibb terminated its manufacturing partnership for the CAR‑T therapy Breyanzi. The affected positions include software engineers, quality‑control and design staff, and manufacturing specialists.
MaineHealth is cutting 83 positions in its information technology and analytics departments, consolidating three teams into one as part of a broader redesign. The reductions eliminate 56 IT roles and 27 of the system’s 63 analytics positions.
Sharp HealthCare announced a reorganization affecting 260 employees, its second round of layoffs in just over a year following the elimination of 315 roles last summer. The San Diego‑based health system, which reported an operating loss of $173.5 million on $5.5 billion in revenue, cited rising costs and federal and state policy changes. Many impacted workers were offered alternative positions within the system.
Also Read
- The Role of Midwives in Addressing America’s Maternal Health Crisis: Insights from OBHG’s Amanda Shafton
- FDA Grants Approval to First-in-Class Mimrylo for Treating Polycythemia Vera
- Acquiring a Drug Patent Application: A Strategy to Extend Monopoly Power?
- Six People with Severe Rheumatoid Arthritis Improved After a Cancer Cell Therapy and Three Stopped Medication
